3,8-Dimethyl-3-(2-(o-tolylamino)thiazol-4-yl)-2,7-dioxaspiro[4.4]nonane-1,6-dione

Catalog No. :
ACCFPN173
CAS No. :
927270-10-8
Molecular Formula :
C19H20N2O4S
Molecular Weight :
372.45

IUPAC Name:3,8-dimethyl-3-(2-(o-tolylamino)thiazol-4-yl)-2,7-dioxaspiro[4.4]nonane-1,6-dione

3,8-Dimethyl-3-(2-(o-tolylamino)thiazol-4-yl)-2,7-dioxaspiro[4.4]nonane-1,6-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,8-Dimethyl-3-(2-(o-tolylamino)thiazol-4-yl)-2,7-dioxaspiro[4.4]nonane-1,6-dione
IUPAC Name3,8-dimethyl-3-(2-(o-tolylamino)thiazol-4-yl)-2,7-dioxaspiro[4.4]nonane-1,6-dione
Molecular FormulaC19H20N2O4S
Molecular Weight372.45
SMILESCC1=CC=CC=C1NC1=NC(C2(C)CC3(CC(C)OC3=O)C(=O)O2)=CS1
InChI KeyZCVUCXZVBWBEDO-UHFFFAOYSA-N
Synonym3,8-dimethyl-3-[2-(2-methylanilino)-1,3-thiazol-4-yl]-2,7-dioxaspiro[4.4]nonane-1,6-dione;2,7-Dioxaspiro[4.4]nonane-1,6-dione, 3,8-dimethyl-3-[2-[(2-methylphenyl)amino]-4-thiazolyl]-
CAS No.927270-10-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACCFPN173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCFPN173 route product structure diagram
    ACCFPN173927270-10-8
Inquiry

2. ACCFPN173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCFPN173 route product structure diagram
    ACCFPN173927270-10-8
Inquiry

Comments (0)